From Pre-clinical to commercial, leverage our data, analytics and insights to drive biopharma success

The Pharma industry is at the cusp of a data and AI revolution. The traditional business model is showing fault lines as recurring clinical failures has led to a declining ROI on R&D. Today, developing a new drug cost upwards of $2.5 billion and over a decade to bring to the market. Further, rising healthcare costs are putting pressure on the industry and governments to embrace a value-driven patient-centric approach. Life science and healthcare datasets have been mired in silos, while Omics, digitization, and IoT are leading the generation towards much larger volumes of data. Pharma is gearing up for an AI and data-driven disruption.

We at Excelra, have over 15 years of experience in supporting the data and analytical needs of the biopharma industry. Over the years, we have built a high-quality scientific data engine powered by human and machine intelligence. This has helped us create valuable data assets from drug chemistry to biomarkers and clinical and real-world evidence. Our Scientists consult with Biopharma companies, offering them bespoke solutions leveraging Cheminformatics, Bioinformatics, Computational Biology and Data Science.

Scroll To Top